Netherlands · Who invested in Alesta Therapeutics?
Alesta Therapeutics's investors include Frazier Life Sciences, Droia Ventures, Novartis, RTW Investments LLC and Thuja Capital, and 2 more on record. Frazier Life Sciences led its latest round.
Netherlands · Series A startup
Who invested in Alesta Therapeutics
Funding summaryUpdated 26 Oct 2026
$67Mraised across 1 round since 2025, from 3 sources
- Latest round
- Series A, $67MJan 2025
- Led by
- Frazier Life Sciences and Droia Ventures
- Investors
- 7 (2 led)
The rounds
- Jan 2025Series A$67M
Frazier Life SciencesLead
Droia VenturesLead
Novartis
RTW Investments LLC
Thuja Capital
RV Invest
SSI Strategy
Reported by Firms' own news pages and 2 others
Founders and team
From Alesta Therapeutics's own website: 9 on the team.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Alesta Therapeutics
How much has Alesta Therapeutics raised?
Alesta Therapeutics has raised $67M across 1 round since 2025.
When did Alesta Therapeutics last raise?
Alesta Therapeutics's most recent round was a Series A of $67M in Jan 2025, led by Frazier Life Sciences.
What was Alesta Therapeutics's biggest round?
Its most recent round, $67M in Jan 2025, is also its largest on record.
Who backed Alesta Therapeutics first?
Alesta Therapeutics's first round on record, in Jan 2025, was backed by Frazier Life Sciences, Droia Ventures and Novartis and 4 others.
What stage is Alesta Therapeutics at?
Alesta Therapeutics's latest named round is a Series A, in Jan 2025.
Where is Alesta Therapeutics based?
Alesta Therapeutics is based in the Netherlands.
Who led Alesta Therapeutics's rounds?
Frazier Life Sciences led the Series A in 2025.
Companies like Alesta Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.